{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:15:20Z","timestamp":1792746920751,"version":"4.5.0"},"reference-count":53,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2019,9,2]]},"DOI":"10.1080\/21645515.2019.1621148","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T17:09:33Z","timestamp":1558544973000},"page":"2060-2065","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":21,"title":["The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles"],"prefix":"10.1080","volume":"15","author":[{"given":"Megan K.","family":"Young","sequence":"first","affiliation":[{"name":"School of Medicine and Menzies Health Institute Queensland,  Griffith University , Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,6,19]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00001"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.480"},{"key":"cit0003","volume-title":"WHO technical report series","author":"WHO","year":"2007"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2006.11.001"},{"key":"cit0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/aob.2017.12.06","volume":"3","author":"Burnouf T","year":"2018","journal-title":"Annals Blood"},{"key":"cit0006","volume-title":"Australian immunisation handbook","author":"Australian Technical Advisory Group on Immunisation","year":"2018"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1071\/NB97032"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.21037\/aob.2018.01.06"},{"key":"cit0009","volume-title":"Hepatitis A: national guidelines for public health units","author":"Communicable Diseases Network Australia","year":"2018"},{"key":"cit0010","volume-title":"Measles: national guidelines for public health units","author":"Communicable Diseases Network Australia","year":"2015"},{"key":"cit0011","first-page":"1","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR - Morbidity Mortality Weekly Rep"},{"key":"cit0012","volume-title":"Canadian immunization guide: part 5 - passive immunization","author":"Public Health Agency of Canada","year":"2017"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v44i12a06"},{"key":"cit0014","volume-title":"Guidelines on post-exposure prophylaxis for measles August 2017","author":"Public Health England","year":"2017"},{"key":"cit0015","volume-title":"Immunoglobulin Handbook: hepatitis A","author":"Public health England","year":"2017"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6743a5"},{"key":"cit0017","volume-title":"Public health control and management of hepatitis A","author":"Mearkle R","year":"2017"},{"key":"cit0018","volume-title":"Rubella: the green book, chapter 28. Immunisation against infectious disease - \u201cThe Green Book\u201d","author":"UK Department of Health","year":"2013"},{"key":"cit0019","volume-title":"Immunisation Handbook 2017","author":"New Zealand Ministry of Health","year":"2018","edition":"2"},{"key":"cit0020","unstructured":"CSL Behring .Product information: Normal Immunoglobulin-VF 2017. Available from: https:\/\/www.cslbehring.com.au\/-\/media\/cslb-australia\/documents\/aus-pis-and-cmis\/normal-immunoglobulin-au-pi-900.pdf?la=en-us&hash=48E460BA88375592764C0AECF0083C074322AABB"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.09.002"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.08.033"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2013.05.004"},{"key":"cit0024","unstructured":"Australian Red Cross Blood Service . Residual risk estimates for transfusion-transmissible infections 2018. [accessed 2018 Mar 27]. https:\/\/transfusion.com.au\/adverse_events\/risks\/estimates."},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.08.003"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6636a5"},{"key":"cit0027","volume-title":"Canadian Immunization Guide: Part. 4 - active vaccines - hepatitis a vaccine","author":"Public Health Agency of Canada","year":"2018"},{"key":"cit0028","unstructured":"Royal College of Paediatrics and Child Health . UK-WHO growth charts \u2013 2\u201318 years 2012. [accessed 2019 Apr 21 ]. https:\/\/www.rcpch.ac.uk\/resources\/uk-who-growth-charts-2-18-years."},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.4161\/hv.25311"},{"key":"cit0030","unstructured":"Public Health Agency of Canada . Canadian immunization guide: table of updates [accessed 2019 Mar 20 ]. https:\/\/www.canada.ca\/en\/public-health\/services\/canadian-immunization-guide\/updates.html."},{"key":"cit0031","first-page":"1","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR - Morbidity Mortality Weekly Rep"},{"key":"cit0032","volume-title":"Canadian immunization guide: part 4 - active immunization - rubella vaccine","author":"Public Health Agency of Canada","year":"2018"},{"key":"cit0033","volume-title":"Canadian immunization guide: part 4 - active vaccines - measles vaccine","author":"Public Health Agency of Canada","year":"2018"},{"key":"cit0034","volume-title":"PHE national measles guidelines","author":"Amirthalingam G","year":"2017"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v44i09a07"},{"key":"cit0036","unstructured":"Public Health Agency of Canada . Contents of immunizing agents available for use in Canada. [updated 2018 Jan 30 ]. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-1-key-immunization-information\/page-15-contents-immunizing-agents-available-use-canada.html."},{"key":"cit0037","unstructured":"Canadian Blood Services . Intravenous immune globulins [accessed 2018 March 20 ]. https:\/\/blood.ca\/sites\/default\/files\/Intravenous_Immune_Globulins_Table.pdf."},{"key":"cit0038","unstructured":"Grifols Therapeutics Inc . Product monograph: gamaSTAN S\/D. [accessed 2018 Feb 6 ]. https:\/\/www.grifols.com\/documents\/17006\/133313\/GamaSTAN-SD-en.pdf\/8166db44-8ec4-44a2-8fa5-f37bcafbf8e6."},{"key":"cit0039","unstructured":"Grifols Therapeutics Inc . Product monograph: iVIGnex. [accessed 2017 July 12 ]. https:\/\/www.grifols.com\/documents\/17006\/133313\/igivnex-ca-en.pdf\/f3121cb8-46ac-4e0e-9828-dfe23bff4f69."},{"key":"cit0040","unstructured":"Shire Pharma Canada ULC . Product monograph: gammagard Liquid. [accessed 2018 May 4 ]. Available from: https:\/\/www.shirecanada.com\/-\/media\/shire\/shireglobal\/shirecanada\/pdffiles\/product%20information\/gammagard-liquid-pm-en.pdf."},{"key":"cit0041","unstructured":"Shire Pharma Canada ULC . Product monograph: gammagard S\/D. [accessed 2018 Jul 13 ]. https:\/\/www.shirecanada.com\/-\/media\/shire\/shireglobal\/shirecanada\/pdffiles\/product%20information\/gammagard-sd-pm-en.pdf."},{"key":"#cr-split#-cit0042.1","unstructured":"Grifols Therapeutics Inc . Product monograph: gamunex. [accessed 2013 Jan 29"},{"key":"#cr-split#-cit0042.2","unstructured":"cited 22 April 2019]. https:\/\/www.grifols.com\/documents\/17006\/186428\/gamunex-en.pdf\/3fd763d1-1b44-467c-b8e0-d9892db8ec0a."},{"key":"cit0043","unstructured":"Octapharma . Product monograph: panzyga [accessed 2019 Aug 29 ]. https:\/\/www.octapharma.ca\/fileadmin\/user_upload\/octapharma.ca\/Product_Monographs\/PANZYGA-PM-EN.pdf."},{"key":"cit0044","unstructured":"NZ Blood . Immunoglobulins. [accessed 2017 Mar 7]. https:\/\/www.nzblood.co.nz\/clinical-information\/transfusion-medicine\/health-professionals-medicine-datasheets\/immunoglobulins\/."},{"key":"cit0045","unstructured":"Datapharm . Medicines compendium (eMC): search results for immunoglobulin - summaries of product characteristics. Surrey, United Kingdom [accessed 2019 April 22]. https:\/\/www.medicines.org.uk\/emc\/search?q=immunoglobulin."},{"key":"cit0046","unstructured":"US Food and Drug Administration . Vaccines, blood & biologics: immune globulins - package inserts. [accessed 2019 Feb 7 . https:\/\/www.fda.gov\/BiologicsBloodVaccines\/BloodBloodProducts\/ApprovedProducts\/LicensedProductsBLAs\/FractionatedPlasmaProducts\/ucm127589.htm."},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1234554"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1327110"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010056.pub2"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.9057"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010586.pub2"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2018.1484449"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tandfonline.com\/doi\/pdf\/10.1080\/21645515.2019.1621148","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2019.1621148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T01:08:56Z","timestamp":1599354536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2019.1621148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,19]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,2]]}},"alternative-id":["10.1080\/21645515.2019.1621148"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2019.1621148","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-03-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}